SEC Form 4 · accession 0002142653-26-000004
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hege Elisabeth Sollie-Zetlmayer
Director
Period of report
Jul 28, 2026
Accepted (ET)
Jul 30, 2026 · 9:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 28, 2026 | A | 4,000 | $0.00 | A | 50,526 | D | |
| Common Stock | Jul 28, 2026 | A | 2,000 | $0.00 | A | 52,526 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $75.39 | Jul 28, 2026 | A | 3,475 | A | Jul 28, 2026 | Jul 27, 2036 | Common Stock | 3,475 | 3,475 | D |
| Stock Option (Right to Buy) | $75.39 | Jul 28, 2026 | A | 1,738 | A | Jul 28, 2026 | Jul 27, 2036 | Common Stock | 1,738 | 1,738 | D |
Explanation of responses
- F1Restricted stock units granted on July 28, 2026, with the shares underlying such restricted stock units vesting in three equal annual installments, commencing on July 28, 2027.
- F2Restricted stock units granted on July 28, 2026, with the shares underlying such restricted stock units vesting on January 2, 2027.
- F3This option was granted on July 28, 2026 and vests over 36 equal monthly installments, commencing on August 28, 2026.
- F4This option was granted on July 28, 2026 and vests over six equal monthly installments, commencing on August 2, 2026.